Earnings Feed
Start Free
Home/Insiders/Silvestro Stephen L
SS
SEC Insider//CIK 0001773461

Silvestro Stephen L

CIK 00017734611 companyWALTHAM, MA
SEC Profile

Transactions

50

Companies

1

Filings

9

CIK

0001773461

Recent Transactions

50 trades
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-12-19+6,546→ 195,462 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-12-19−6,546→ 6,547 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-12-19$13.51/sh−1,594→ 193,868 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2025-10-03$18.75/sh−1,620→ 188,916 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-10-03−6,649→ 0 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-10-03+6,649→ 190,536 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2025-08-21+15,625→ 183,887 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2025-08-21+35,156→ 35,156 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2025-05-15+80,884→ 80,884 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2025-05-15+46,948→ 168,262 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-03-01$5.18/sh−572→ 121,314 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-03-01−1,928→ 0 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-03-01+1,928→ 121,886 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-02-15$6.64/sh−2,298→ 119,958 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-23+41,408→ 122,256 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2024-12-23+77,742→ 77,742 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-19$4.75/sh−2,576→ 80,848 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-12-19−6,546→ 13,093 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-19+6,546→ 83,424 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-10-03+6,649→ 79,495 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-10-03−6,649→ 6,649 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-10-03$7.83/sh−2,617→ 76,878 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-05-02−90,000→ 0 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-05-02$10.70/sh−35,415→ 72,846 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-05-02+90,000→ 108,261 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-15+7,750→ 13,706 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01$15.95/sh−668→ 5,956 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-03-01−1,927→ 1,928 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01$15.95/sh−572→ 18,261 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01+1,927→ 18,833 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01+1,927→ 6,624 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2024-02-15+7,750→ 16,906 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2023-12-19+19,639→ 19,639 total
  • Award
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-12-19+19,639→ 19,639 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-10-03−6,649→ 13,298 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-10-03$7.06/sh−1,952→ 4,697 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-10-03+6,649→ 6,649 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-03-01+1,927→ 5,127 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-03-01−1,927→ 3,855 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-03-01$18.11/sh−668→ 4,459 total
  • Award
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2022-10-03+19,947→ 19,947 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2022-10-03+39,055→ 39,055 total
  • Purchase
    OptimizeRx Corp$OPRX

    Common Stock

    2022-08-16$15.66/sh+3,200→ 3,200 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2022-03-01+11,726→ 11,726 total
  • Award
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2022-03-01+5,782→ 5,782 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-12-17$7.51/sh+13,241→ 13,241 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-12-17−13,241→ 38,511 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock pursuant to 10B5-1 plan

    2021-12-17$54.87/sh−13,241→ 0 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-11-17$7.51/sh+13,241→ 13,241 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock pursuant to 10B5-1 plan

    2021-11-17$73.98/sh−13,241→ 0 total

Companies

1

Recent Filings

9

Address

C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302

WALTHAM, MA, 02453

View on SEC.gov